Today: 21 May 2026
EOSE stock jumps nearly 10% as Eos tees up a Jan. 14 update — what investors are watching
13 January 2026
1 min read

EOSE stock jumps nearly 10% as Eos tees up a Jan. 14 update — what investors are watching

NEW YORK, Jan 13, 2026, 13:56 ET — Regular session

  • Shares of Eos Energy Enterprises climbed roughly 9% during Tuesday afternoon trading.
  • Traders highlighted positioning moves ahead of the company’s “Eos in Focus” webcast scheduled for Wednesday.
  • The stock showed volatility, trading on heavy volume with a broad intraday range.

Shares of Eos Energy Enterprises rose Tuesday, building on a recent streak ahead of the company’s webcast set for Wednesday.

The Nasdaq-listed battery maker has attracted quick traders this month, with its next catalyst set to drop before the bell. Some investors expect the event to shed new light on operations and funding, though others caution that the stock has already run hard, setting a tough benchmark.

Shares jumped roughly 9.2% to $17.62 in afternoon trading, having started the day at $16.54.

Eos announced it plans to hold an event called “Eos in Focus” on Wednesday, Jan. 14, following the company’s note about upcoming business updates this week. Insider Monkey

The company has scheduled the webcast for 8:30 a.m. ET on Wednesday.

Tuesday saw the stock fluctuate from $16.21 up to $17.75, with over 20 million shares exchanged by mid-afternoon.

Eos develops and markets zinc-based energy storage systems, positioning them as a longer-duration alternative to lithium-ion.

Investors are now focused on one thing: clearer figures on execution. Concrete targets for production, deliveries, and cash flow could shift sentiment fast, especially following recent sharp daily swings.

But the situation works both ways. If Wednesday’s update lacks detail or signals delays, rising costs, or a bleaker outlook, the stock could quickly lose the gains it made, especially with how crowded this trade has grown.

The next key event is the “Eos in Focus” webcast at 8:30 a.m. ET on Wednesday. Investors will be digging into the company’s remarks for clues on how 2025 might shape up and what to expect in 2026. investors.eose.com

Stock Market Today

  • SpaceX Set to Go Public: Key Details and Market Impact
    May 20, 2026, 8:02 PM EDT. SpaceX, founded by Elon Musk, is poised to go public, joining hundreds of companies that raised $70 billion in U.S. equity markets last year. Going public means the company will offer shares for sale on stock exchanges, allowing investors to buy ownership stakes. This move could unlock significant capital for SpaceX's ambitious space ventures, while providing early investors a chance to realize gains. The offering is closely watched amid a strong appetite for tech and aerospace stocks, reflecting broader market interest in innovation-driven firms.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
SOLS stock jumps as Solstice Advanced Materials targets $220 million Virginia ballistic-fiber buildout
Previous Story

SOLS stock jumps as Solstice Advanced Materials targets $220 million Virginia ballistic-fiber buildout

Fabrinet (FN) stock jumps 8% after CPI report as traders eye next earnings test
Next Story

Fabrinet (FN) stock jumps 8% after CPI report as traders eye next earnings test

Go toTop